Neurobiological Technologies Inc /CA/ - Current report filing (8-K)
November 20 2007 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 19, 2007
NEUROBIOLOGICAL TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware
|
|
000-23280
|
|
94-3049219
|
(State of Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification No.)
|
|
|
2000 Powell Street, Suite 800, Emeryville,
California
|
|
94608
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (510) 595-6000
NOT APPLICABLE
(Former Name or
Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
On November 19, 2007, Neurobiological
Technologies, Inc. (the Company) received notice from the NASDAQ Stock Market that the Company had regained compliance with the NASDAQ continued listing standards set forth in NASDAQ Marketplace Rule 4310(c)(3)(B). On November 20,
2007, the Company issued a press release announcing receipt of this notice from NASDAQ. A copy of this press release is filed herewith as Exhibit 99.1.
Item 9.01
|
Financial Statements and Exhibits
|
(d) Exhibits
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press Release, dated November 20, 2007
|
* * *
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: November 20, 2007
|
|
|
NEUROBIOLOGICAL TECHNOLOGIES, INC.
|
|
|
By:
|
|
/s/ Craig W. Carlson
|
|
|
Craig W. Carlson
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
|
|
99.1
|
|
Press Release, dated November 20, 2007
|
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Aug 2023 to Aug 2024